Literature DB >> 7335

Blockade by burimamide of the restorative effect of histamine in tetrodotoxin-treated heart preparations.

F Ledda, L Mantelli, A Mugelli.   

Abstract

1 In isolated heart preparations in which fast sodium channels were blocked by tetrodotoxin (2-4 x 10(-5) M), excitability was restored by histamine (6 x 10(-6) M to 10(-5) M). 2 This effect was antagonized by EDTA (2 X 10(-6) M),D600 compound (0.5mug/ml) and the H2-receptor antagonist, burimamide(2 X 10(-4) M).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7335      PMCID: PMC1667117          DOI: 10.1111/j.1476-5381.1976.tb07474.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

2.  Histamine effects on cardiac contractility, phosphorylase and adenyl cyclase.

Authors:  J H McNeill; L D Muschek
Journal:  J Mol Cell Cardiol       Date:  1972-12       Impact factor: 5.000

3.  Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors.

Authors:  M Kohlhardt; B Bauer; H Krause; A Fleckenstein
Journal:  Pflugers Arch       Date:  1972       Impact factor: 3.657

4.  Restoration effects of histamine on action potential in potassium-depolarized guinea-pig papillary muscle.

Authors:  S Houki
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-11

5.  Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate.

Authors:  J H McNeill; S C Verma
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

6.  Effects of histamine and noradrenaline on contractile force of guinea-pig ventricular strips: antagonism by burimamide and metiamide.

Authors:  F Moroni; F Ledda; R Fantozzi; A Mugelli; P F Mannaioni
Journal:  Agents Actions       Date:  1974-12
  6 in total
  9 in total

1.  A histamine-induced decrease of action potential duration in cardiac muscle mediated by the H2 receptors.

Authors:  F Ledda; A Mugelli; L Mantelli
Journal:  Agents Actions       Date:  1977-07

2.  Effects of H1- and H2-receptor antagonists on calcium-dependent action potentials produced by histamine in rabbit left auricles depolarized by potassium.

Authors:  V Kecskeméti
Journal:  Agents Actions       Date:  1981-04

3.  Calcium antagonistic and antiarrhythmic actions of CPU-23, a substituted tetrahydroisoquinoline.

Authors:  H Dong; J Z Sheng; C M Lee; T M Wong
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

4.  Some characteristics of the inotropic effects of histamine H1- and H2-receptor agonists in comparison with those of alpha- and beta-adrenoceptor agonists.

Authors:  L Mantelli; S Amerini; A Picchi; A Mugelli; F Ledda
Journal:  Agents Actions       Date:  1982-04

5.  Role of the oscillatory afterpotentials in the arrhythmogenic action of histamine.

Authors:  S Amerini; F Fusi; A Mugelli
Journal:  Agents Actions       Date:  1985-04

6.  Indirect evidence for a role of phosphatidylinositol turnover in the cardiac response to H1-receptor stimulation.

Authors:  L Mantelli; F Ledda; L Capanni; V Corti
Journal:  Agents Actions       Date:  1988-07

7.  Histamine and abnormal automaticity in barium- and strophanthidin-treated sheep Purkinje fibers.

Authors:  E Cerbai; S Amerini; A Mugelli
Journal:  Agents Actions       Date:  1990-08

8.  Dysrhythmias caused by histamine release in guinea pig and human hearts.

Authors:  R Levi; A A Chenouda; J P Trzeciakowski; Z G Guo; L M Aaronson; R D Luskind; C H Lee; W A Gay; V A Subramanian; J C McCabe; J C Alexander
Journal:  Klin Wochenschr       Date:  1982-09-01

Review 9.  Channel-mediated calcium current in the heart.

Authors:  W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.